staurosporine has been researched along with Experimental Mammary Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dhorma, LP; Kim, MH; Maeng, HJ; Maturi, A; Mirzaei, A; Nangunuri, BG; Ragam, R; Teli, MK; Venkanna, A; Vo, DK | 1 |
| Bradbury, EM; Crissman, HA; Guo, XW; Swank, RA; Th'ng, JP | 1 |
| Birkedal-Hansen, B; Birkedal-Hansen, H; Lyons, JG; Pierson, MC; Whitelock, JM | 1 |
| Bradbury, EM; Guo, XW; Hall, LL; Teplitz, RL; Th'ng, JP | 1 |
| Aguirre Ghiso, JA; Alonso, DF; Arregui, C; Bal de Kier Joffé, E; Farías, EF | 1 |
| Anderson, HJ; Gowdy, PM; Roberge, M | 1 |
| Bradbury, EM; Gadbois, DM; Hamaguchi, JR; Swank, RA | 1 |
7 other study(ies) available for staurosporine and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.
Topics: Animals; Antineoplastic Agents; Aza Compounds; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Epigenesis, Genetic; Female; HEK293 Cells; Histone-Lysine N-Methyltransferase; Humans; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Microsomes, Liver; Molecular Docking Simulation; Molecular Structure; Quinones; Spiro Compounds; Structure-Activity Relationship | 2022 |
Inhibition of histone phosphorylation by staurosporine leads to chromosome decondensation.
Topics: Alkaloids; Animals; Cell Cycle; Cell Line; Chromosomes; Electrophoresis, Polyacrylamide Gel; Female; G2 Phase; Histones; Mammary Neoplasms, Experimental; Metaphase; Mice; Mitosis; Phosphoproteins; Phosphorylation; Protamine Kinase; Staurosporine; Tumor Cells, Cultured | 1994 |
Interleukin-1 beta and transforming growth factor-alpha/epidermal growth factor induce expression of M(r) 95,000 type IV collagenase/gelatinase and interstitial fibroblast-type collagenase by rat mucosal keratinocytes.
Topics: Alkaloids; Animals; Cell Line; Collagenases; Dexamethasone; Endopeptidases; Enzyme Induction; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Fibroblasts; Gelatinases; Interleukin-1; Keratinocytes; Mammary Neoplasms, Experimental; Molecular Weight; Mouth Mucosa; Protein Kinase C; Rats; Staurosporine; Tetradecanoylphorbol Acetate; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1993 |
A brief staurosporine treatment of mitotic cells triggers premature exit from mitosis and polyploid cell formation.
Topics: Alkaloids; Animals; Antineoplastic Agents; CDC2 Protein Kinase; DNA, Neoplasm; Enzyme Inhibitors; G1 Phase; Histones; Mammary Neoplasms, Experimental; Metaphase; Mice; Mitosis; Nocodazole; Phosphorylation; Polyploidy; Staurosporine; Tumor Cells, Cultured | 1996 |
A phospholipase D and protein kinase C inhibitor blocks the spreading of murine mammary adenocarcinoma cells altering f-actin and beta1-integrin point contact distribution.
Topics: 1-Butanol; Actins; Adenocarcinoma; Animals; Butanols; Cell Adhesion; Cell Division; Enzyme Inhibitors; Genistein; Integrin beta1; Isoflavones; Mammary Neoplasms, Experimental; Mice; Microscopy, Fluorescence; Phosphatidic Acids; Phospholipase D; Protein Kinase C; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1997 |
Entry into mitosis without Cdc2 kinase activation.
Topics: Animals; CDC2 Protein Kinase; cdc25 Phosphatases; Cell Cycle Proteins; Chromosomes; Enzyme Activation; Enzyme Inhibitors; G2 Phase; Lamins; Mammary Neoplasms, Experimental; Mice; Microtubules; Mitosis; Nuclear Envelope; Nuclear Proteins; Okadaic Acid; Phosphoprotein Phosphatases; Protein Phosphatase 1; Protein Tyrosine Phosphatases; Staurosporine; Tumor Cells, Cultured | 1998 |
Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases.
Topics: Alkaloids; Amino Acid Sequence; Animals; CDC2 Protein Kinase; Cell Line; Female; G2 Phase; Kinetics; Mammary Neoplasms, Experimental; Mice; Molecular Sequence Data; Peptides; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Staurosporine; Substrate Specificity | 1992 |